On 2026-08-11, BridgeBio Oncology Therapeutics, Inc (BBOT) announced earnings per share of $-0.71 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-0.55.
The next expected annoucement date for quarterly earnings is 2026-11-11, with an average estimated earnings per share of $-0.56 for the fiscal quarter ending 2026-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-11 | 2026-06-30 | $-0.55 | $-0.71 |
| 2026-05-12 | 2026-03-31 | $-0.51 | $-0.53 |
| 2026-03-05 | 2025-12-31 | $-0.67 | $-0.49 |
| 2025-11-12 | 2025-09-30 | $-0.41 | $-1.03 |